News - Sandoz, Markets & Marketing


Current filters:

SandozMarkets & Marketing

Popular Filters

Tacrolimus Sandoz gets sole subsidy supply status in New Zealand

Tacrolimus Sandoz gets sole subsidy supply status in New Zealand


New Zealand’s Pharmaceutical Management Agency PHARMAC has decided to award immunosuppressant drug…

Asia-PacificGenericsImmunologicalsMarkets & MarketingNew ZealandNovartisPricingSandozTacrolimus Sandoz

Global biosimilar drug revenues will reach $2,445 million in 2013, says Visiongain


The world market for biosimilar drugs will be worth $2,445 million in 2013, growing by more than 20%…

BiotechnologyCellTrionGenericsGlobalHospiraMarkets & MarketingSandoz

EU Commission sends antitrust complaint to Johnson & Johnson and Novartis


The European Commission has informed US health care giant Johnson & Johnson (NYSE: JNJ) and Swiss drug…

DuragesicEuropefentanylGenericsJanssen-CilagJohnson & JohnsonLegalMarkets & MarketingNeurologicalNovartisPatentsPharmaceuticalSandoz

"Sandoz will be the leading biosimilars company in 2012," says Visiongain


Sandoz, the generics unit of Swiss drug major Novartis (NVN: VX), will retain its position as the global…

BiotechnologyDr Reddy's LaboratoriesGenericsGlobalHospiraMarkets & MarketingNovartisSandoz

Sandoz links with Cinpharm for generics in Sub-Saharan Africa


Sandoz, the generics business of Swiss drug major Novartis (NOVN: VX), said yesterday that its German…

CinpharmGenericsMarkets & MarketingNovartisRest of the WorldSandoz

Novartis expands transplant portfolio with first branded generic tacrolimus


Swiss drug major Novartis has announced the US introduction and availability of Hecoria (tacrolimus)…

Astellas PharmaGenericsHecoriaImmunologicalsMarkets & MarketingNorth AmericaNovartisPrografSandoztacrolimus

Ring in generics in 2012 and beyond, says Zacks Equity Research


The New Year is expected to be a happy beginning for generic companies like Teva Pharmaceuticals (Nasdaq:…

Dr Reddy's LaboratoriesGenericsMarkets & MarketingNorth AmericaPatentsRanbaxy LaboratoriesSandozTeva Pharmaceutical IndustriesWatson Pharmaceuticals

Back to top